Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients.

Frontiers in endocrinology - 1 Jan 2022

Capezzone Marco, Sagnella Alfonso, Cantara Silvia, Fralassi Noemi, Maino Fabio, Forleo Raffaella, Brilli Lucia, Pilli Tania, Cartocci Alessandra, Castagna Maria Grazia

Abstract excerpt

Introduction: Survival rates in patients with non-medullary thyroid carcinoma (NMTC) are high, increasing the possibility to develop a second malignant neoplasm (SMN). Many studies investigated the relationship between increased risk of SMN in NMTC patients treated with radioiodine, but few data are available about the impact of family history (FH) of thyroid cancer on SMN risk. Purpose: To assess the risk of SMN...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Iodine Radioisotopes
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms, Second Primary

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35311228
DOI: 10.3389/fendo.2022.845954
PMCID: PMC8931333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients.PMID 35311228Read ↗

The Long-Term Outcomes of the Second Generation of Familial Nonmedullary Thyroid Carcinoma Are More Aggressive than Sporadic CasesSemantic proximity Read ↗

Familial nonmedullary thyroid carcinoma.Semantic proximity Read ↗

Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC)Semantic proximity Read ↗

FAMILIAL NON-MEDULLARY THYROID CARCINOMA.Semantic proximity Read ↗

In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.Semantic proximity Read ↗

Increased Risk for Nonmedullary Thyroid Cancer in the First Degree Relatives of Prevalent Cases of Nonmedullary Thyroid Cancer: A Hospital-Based StudySemantic proximity Read ↗

Familial nonmedullary thyroid carcinoma.Semantic proximity Read ↗

Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings.Semantic proximity Read ↗

Relationship between affected family members and clinical aggressiveness in Familial non-medullary thyroid carcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.Semantic proximity Read ↗

Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.Semantic proximity Read ↗

Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.